Welcome to our dedicated page for AEHR TEST SYSTEMS SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
Aehr Test Systems (AEHR) is soliciting proxies for its 2026 annual meeting on October 19, 2026 at its Fremont, California headquarters. Holders of 32,659,546 shares of common stock as of August 27, 2026 may vote on electing six directors, ratifying BPM LLP as auditor for fiscal 2027, and approving an advisory say‑on‑pay resolution.
The board has an independent chairman, three key committees composed entirely of independent directors, and a Code of Conduct and Ethics. Outside directors receive role‑based cash retainers and annual RSU grants that vest quarterly, with stock ownership guidelines of at least one year of cash compensation. The proxy details an executive pay program emphasizing at‑risk bonuses and RSUs, change‑in‑control and severance agreements for the CEO and two other NEOs, a Dodd‑Frank compliant clawback policy, and the board’s oversight of cybersecurity risk, including regular Audit Committee briefings and an information security insurance policy.
AEHR TEST SYSTEMS (AEHR) reported that Executive VP of R&D Didier Wimmers had 317 shares of common stock withheld on September 3, 2026 to satisfy tax withholding obligations upon vesting of restricted stock units, which the company notes does not represent a market sale. Following this tax-withholding disposition, Wimmers holds 12,379 shares directly, including shares underlying unvested restricted stock units, and no Rule 10b5-1 trading plan is reported.
AEHR TEST SYSTEMS (AEHR) reported an insider equity transaction by CFO Chris Siu. On 2026-09-01, 496 shares of common stock were withheld at $76.59 per share to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares; this was not an open-market sale. Following this tax-withholding disposition, Siu directly held 77,328 shares, including shares subject to unvested restricted stock units, and indirectly held 5,706 shares by trust.
AEHR TEST SYSTEMS (AEHR) reported that executive officer Vernon Rogers, Exec VP of Sales & Marketing, sold a total of 5,994 shares of common stock in open market or private transactions. The sales occurred on August 14, 2026 (two trades of 1,000 shares at $134.00 and $139.00) and on August 17, 2026 (3,994 shares at $143.77). A footnote explains that the amount reported for one transaction includes shares subject to unvested restricted stock units. The Rule 10b5-1 trading plan checkbox was not marked as applying to these transactions.
AEHR insider Vernon I. Rogers filed to potentially sell 3,994 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ, with an indicated aggregate value of $574,217.38 and an anticipated sale date of August 17, 2026. The disclosure also lists prior equity compensation events where restricted stock vested on multiple dates in 2025, and notes that 2,000 shares of common stock were sold on August 14, 2026 for $273,000.00.
AEHR TEST SYSTEMS Chief Operating Officer Adil Engineer reported a bona fide gift of 500 shares of Common Stock on 2026-08-14, donated to the Engineer Z&A Giving Fund. Following the donation, he holds 46,477 shares directly, which includes shares subject to unvested restricted stock units.
AEHR TEST SYSTEMS director Howard T. Slayen reported a sale of 5,700 shares of Common Stock on August 14, 2026 at an average price of $133.0288 per share in an open-market or private transaction. Following this sale, he holds 140,667 shares directly, including shares subject to unvested restricted stock units.
AEHR TEST SYSTEMS director Rhea J. Posedel, through a trust, reported selling 5,973 shares of common stock on 2026-08-14 in a sale described as an open market or private transaction at $140.00 per share. After this sale, the trust holds 381,989 indirect shares, and a separate line shows 47,156 direct shares, which include shares subject to unvested restricted stock units.
AWM Investment Company, Inc., a Delaware corporation and investment adviser to several Special Situations funds, reports its beneficial ownership of common stock of AEHR TEST SYSTEMS in this amended Schedule 13G.
AWM reports beneficial ownership of 374,808 shares of AEHR common stock, representing 1.1% of the class, with sole voting and dispositive power over all reported shares and no shared power. The position is held through four funds: 179,296 shares by SSFQP, 51,265 by Cayman, 25,089 by TECH, and 119,158 by TECH II. The filing notes that this represents ownership of 5 percent or less of the outstanding common stock.